Innovator Case Studies: Oncology Networks

Similar documents
Watson Summit Prague 2017

London Regional Cancer Program

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

Georgia Cancer Quality Information Exchange

The Journey towards Total Wellbeing A Health System s Innovative Approach

REPORT. A Model Clinical Trials System for the 21st Century

Addressing Gaps in MS Care. November 6, :00 AM - Noon

FAMILY & CHILDREN S SERVICES STRATEGIC PLAN

HOW TO MAXIMIZE PATIENT RECRUITMENT IN ONCOLOGY TRIALS A BIOPHARMA DIVE PLAYBOOK

Member-centered cancer care In Georgia

Chronic Care North America update Coloplast Capital Markets Day 2018 Manu Varma, Senior Vice President, Chronic Care Management, NA

We are a network of successful REALTORS, advancing women as professionals and leaders in business, the industry and the communities we serve.

OAMT ONCOLOGY ACCOUNT MANAGEMENT TRAINING. September 20 22, 2016 ARIA Resort & Casino, Las Vegas, NV. For the Life Sciences Industry

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

Insurance Providers Reduce Diabetes Risk Through CDC Program

DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014

A Comprehensive Guide for 2017 SPONSORSHIP & UNDERWRITING Programs and Services

A Comprehensive Guide for 2014 SPONSORSHIP & UNDERWRITING Programs and Services

Health for Humanity 2020 Goals 2

The changing demand of cancer services in Hong Kong can be summarized as follows:

Toward a healthier 2020

Boehringer Ingelheim Biopharmaceuticals in China. Your Reliable Contract Manufacturing Solution Provider

What do we mean by brand value (innovation) within the pharmaceutical sector? Biomedicine Master Program, Lund University, Sweden

Murtha Cancer Center The DoD Cancer Center of Excellence

Strategic Planning For Oncology Services And Why It Is So Vital In Our Current Environment

C-Change Making the Business Case Questions & Answers

Position Profile Chief Executive Officer Feeding America San Diego San Diego, CA

A Comprehensive Guide for 2016 SPONSORSHIP & UNDERWRITING Programs and Services

WELLPOINT RESPONDS TO ANCO s COMMENTS

Healthcare for the Emerging Middle Class

January 30, 2018 Dow Wilson President and Chief Executive Officer

CONNECTING ABUNDANCE WITH NEED 2018 REPORT TO THE COMMUNITY

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE

CEO Operational Report. Annual General Meeting 23 October 2013

An exciting combination in a high growth, high margin Nutrition category. Name of chairman

together Health, Mobility and Equitable Prosperity Rides to Wellness Executive Summit March 11, 2015, Washington DC

Photocure ASA Executing the Strategy

Clinical Pathways in the Oncology Care Model

2018 INFUSE CALL FOR INNOVATION

Managing Global EHS Risk: A Solution. Katie Florio Alizabeth Aramowicz Smith July 19 th, 2017

Mental Health Matters

Planning Case Study. Barbara Ann Karmanos Cancer Institute McLaren Health Care Detroit, Michigan

Regional Clinical Co-Lead (Physician) Role Opportunity

UNMC Nebraska Medicine Strategic Plan

Immunotherapy in Oncology

Boehringer Ingelheim Pharmaceuticals, Inc. & Univision. Making Diabetic Hispanics Healthier

Sponsorship & Vendor Partnership Opportunities

Note: This is an authorized excerpt from 2016 Healthcare Benchmarks: Digital Health To download the entire report, go to

CONSTITUTION SOUTHAMPTON CHILDREN & YOUNG PEOPLE S TRUST PARTNERSHIP

Fighting Bird Flu with Technology

Committed to Environment, Health and Safety

Collective Impact Report

2017 Rural Health Network Summit

The Economic and Social Council, Recalling the United Nations Millennium Declaration13 and the 2005 World Summit Outcome, 1

Improving health service delivery through telehealth expansion in Queensland

Comprehensive, Conservative Care Model: ChiroFirst Study

Partnering with Doctors through Co-Management

LEADERSHIP PROFILE. CURE Childhood Cancer believes that childhood cancer can be cured in our lifetime. -- CURE Childhood Cancer s Vision

The American College of Obstetricians and Gynecologists Office of Global Women s Health Strategic Plan

PRESS RELEASE FOR IMMEDIATE RELEASE SINGAPORE INSTITUTES COLLABORATE WITH SAMSUNG MEDICAL CENTER TO IMPROVE TREATMENT OF LIVER CANCER

The value of multidisciplinary tumor boards in cancer care

Oncology Management at HAP. John Calabria, DO, Medical Director

Strategy at Work. MedStar Health. Engaging people, improving performance

Population Council Strategic Priorities Framework

South West Regional Cancer Program. Cancer Plan

SeniorMed Education Forum 2008 Piecing Together Today s Senior Healthcare Puzzle. May 1, Tampa Marriott Westshore

Public-Private Partnerships: Limelight on Diabetes. Renuka Gadde VP, Global Health October 18, 2012

SUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS

7TH ANNUAL AQC GLOBAL QUALITY SUMMIT SPONSORSHIP OPPORTUNITIES

NAVIFY Tumor Board NAVIFY

AIDS Action Committee & Fenway Health

Photocure ASA Executing the Strategy

Provider Service Model. Collaborating for Success Jodi Stockslager, Sr. Provider Advocate, Provider Relations

CORPORATE PROFILE 2018

Uses of the NIH Collaboratory Distributed Research Network

Table of Contents. 1. About Solvay Solvay at a Glance Group Portfolio Transforming Solvay Solvay s Portfolio Upgrade 7

Linking Public Interests to Ensure Sustainable Statewide Quitlines

AVEO Oncology Announces Strategic Restructuring. AVEO to Host Conference Call Wednesday, June 5 at 8:30 a.m. ET

Solutions for Language Services in Healthcare

Personalized medecine Biomarker

Leveraging Your Cancer Registry: A Strategy for Survey Success

Using the Arts to Advance Health Literacy

a case to support THE HEART & VASCULAR CENTER

ACO Congress Conference Pre Session Clinical Performance Measurement

ADVOCACY IN ACTION TO ACHIEVE GENDER EQUALITY AND THE SUSTAINABLE DEVELOPMENT GOALS IN KENYA

Embargoed for release until Noon Pacific time, August 8, 2007

INVESTOR PRESENTATION

R e s e a r c h S t r a t e g y

The summit and its purpose

STRATEGIC PLAN

LEVINE CANCER INSTITUTE. Brand Articulation and Messaging Platform

Oncology Clinical Pathways: Making Treatment Decisions in the Era of Patient-Centered, Personalized Cancer Care June 12, 2017

Opportunities and Challenges in the Development of Companion Diagnostics

Connecticut Family Stability Pay for Success Project FACT SHEET

2 Surgeries, a Spinal Cord Stimulator and the $500,000 Difference

RAPID DIAGNOSIS AND TREATMENT OF MDR-TB

Where Are We Going? Lisa C. Richardson, MD, MPH Division Director

Improving Diabetes Care A Roadmap to Better Chronic Care

Walgreens. Specialty Pharmacy Marketing Video

Transcription:

Innovator Case Studies: Oncology Networks J. Ike Nicoll Chief Executive Officer Cancer Clinics of Excellence Alan Armer, Ph.D. Vice President, Research & Development Catholic Health Initiatives Cancer Clinics of Excellence J. Ike Nicoll Chief Executive Officer, Cancer Clinics of Excellence 1

CCE History Concept developed in late 2005 Assembled leading community based oncology practices from across the country Focused on clinically integrating practices, around evidenced based treatment protocols and quality initiatives, to enable them to effectively compete in the evolving healthcare marketplace Extended significant effort developing an appropriate business plan and legal structure Evaluated and select a strategic partner to assist in developing the business Launched the launch in April 2007 3 What is CCE? CCE is one of the largest oncology physician services companies in the United States Today, the organization is comprised of 21 oncology practices in more than a dozen states who share a common vision of delivering high-quality, cost-effective cancer care to their patients The company is developing a comprehensive set of evidencebased treatment protocols and an information technology platform that will allow the practices to prove, for the first time, their quality and cost-effectiveness on a real time basis CCE will leverage it s unique capabilities to developing meaningful relationships with 4 2

Our Business Structure CCE Partners CCE Oncology Practice(s) 5 CCE Partners CCE Partners is a national network of cancer clinics owned and governed by the independent member practices. These practices resolutely share the vision of clinically integrating around the highest clinical and quality standards CCE Partners is responsible for Developing evidenced-based treatment protocols (ETP) Developing meaningful and measurable quality standards and initiatives Enforcing the organizations compliance standards 6 3

CCE CCE is the management company responsible for providing the resources and infrastructure necessary to achieve CCE Partners objectives CCE is responsible for Providing the management & operational resources Developing and implementing the technology platform required to collect clinical, operational, and financial information Providing data analysis and reporting capabilities Developing business relationships with various industry partners based on the organization s unique capabilities 7 Current CCE Membership 21 Community Based Oncology Practices 14 States 230 Medical Oncologists Approximately 5% of all Community Oncologists 8 4

Future CCE Membership Developing a national network of quality oncology practices Creating geographic concentration in key regions (Metro, Suburb, Rural) # Med Oncologist 1000 500 0 (5%) 230 CCE Membership Projection (Approx % of all Community Oncologists) (14%) (9 %) 700 400 Launch April 08 April 09 9 Why We Did It: Market Dynamic Community oncology practices are facing a growing list of challenges: Escalating costs of cancer care is resulting in growing controls over physician decisions Declining reimbursement is resulting in increasing financial pressure on the practices Inability to work with Payers to develop a reimbursement model that focuses on quality and cost effectiveness Growing realization that practices need to demonstrate the quality of the care they deliver (Patients, Employers, Payers) Individual practices cannot fund and develop the necessary management and technology infrastructure 10 5

Why We Did It: Market Dynamic (cont (cont d) Practices realized the need to develop a national organization that focuses on: Developing evidence based treatment protocol; Collecting clinical and drug decision data at the point of care; Utilizing this information to prove the quality of their care and thus differentiate themselves on a local and national level; Participating in the economic value created by documenting cost effective, high quality care 11 Why is CCE Unique Practices own and direct the organization Members came together on a voluntary basis Develops & enforces meaningful compliance standards Develops unique Evidence Based Treatment Protocols & quality standards Collecting patient data at the point of care on a nationwide basis 12 6

Where Are We Today Completed the initial development of ETP s & Quality Standards: Breast, Colorectal, Lung, Supportive Care Implementing the information technology platform Lynx Mobile Platform Piloting EMR interfaces Developing the clinical and operational processes within each practice Creating practice metrics and benchmarks Developing initial projects with Pharma and Payers 13 Catholic Health Oncology Network A Model for Optimizing Community Hospital Cancer Care Alan Armer Vice President, Research & Development Catholic Health Initiatives 7

Profile of Catholic Health Initiatives National nonprofit health corporation based in Denver, CO Second largest Catholic health system in the U.S. Total revenues of $7.1 billion 66,000 full- and part-time employees 5 community-based health ministries A microcosm of the U.S. Health System Presence in 19 states (68 rural and urban communities) 73 Hospitals, 21 with Critical Access Hospital designation 42 long-term care, assisted and independent living and residential facilities 2 community based health organizations 2 15 Catholic Health Oncology Network Vision: An integrated, system-wide oncology clinical trial, clinical research and multi-disciplinary care initiative focused on delivering a new standard of oncology care and quality Clinical Trials Multi-d Care Research ~1.4 million new cancer diagnosis will be made in 2007 15% of all patients (210,000) will be treated in 61 NCI-designated cancer centers Remaining 85% of patients (1,190,000) will be treated at community hospitals 2 16 8

Catholic Health Oncology Network (cont Become a highly sought after partner in the clinical development of new therapeutic approaches to cancer treatment (cont d) Raise the bar for how CHI s s community hospitals deliver cancer care Clinical Trials Become a gold standard biorepository and leader in biospecimen research Research Multi-D Care Establish multi-disciplinary care as the standard for treating cancer patients across CHI 17 Network-based Clinical Trials Rationale Clinical trials offer patients the latest advances in cancer care CHI can address the many needs of clinical trial sponsors: Access to large, diverse pools of protocol-eligible patients across multiple disease conditions Participation by highly qualified, proven clinical investigators Centralized administration and systems to deliver quality clinical data in a timely manner Goals Locally offer unique state-of-the-art clinical trials to CHI patients Address barriers in race, gender, geography and access to high quality cancer care Design new trials and quickly transfer gained knowledge of cancer treatment throughout CHI Begin to work with industry partners to develop personalized cancer care treatment approaches 18 9

Network-based Clinical Trials Functional Organization HOSP HOSP TRIAL INTAKE (Central w/in CHON) Central coordination of services & procedures to bring in new trials HOSP CHON HOSP HOSP TRIAL OUTPUT (at hospitals) Local management of activities necessary to conduct trials Status Enrolled a total of 13 CHIhospitals in CHON 5 of these MBO s selected to participate in an NCI program to help bring state-of-the-art cancer care to patients in community hospitals across the U.S. Signed agreement with pharmaceutical firm for non-small cell lung cancer observational study Negotiating with a major pharmaceutical firm for a therapeutic cancer trial 19 Network-based Biorepository & Biospecimen Research Collaborate with government and industry partners to: Develop and implement quality standards for procuring, processing and testing biospecimens Design epidemiologic studies utilizing CHONwide patient cohorts Developing clinically applicable translational research tools and approaches to personalized cancer care treatment 20 10

Network-Based Multidisciplinary Care Establish multi-d care as the standard for care throughout CHI: Offer a team approach to cancer treatment Develop structured, actively managed communication Provide consistent, full range of therapeutic options for all patients Provide guideline-driven, standardized treatment plans Include patients in treatment choice and planning 21 Network-Based Multidisciplinary Care Phase I: Network-wide wide Tele-Video Conferencing Installing an integrated tele-video conferencing system that will link oncology programs across CHON Working with physicians, nurses and patients to reinforce the positive clinical benefit of multidisciplinary care Selectively begun to simulcast multi-disciplinary conferences Bi-weekly CHON planning conferences Facilitate clinical trial entry Tele-video consultation/referral to all specialties for most difficult/unique patient cases 22 11

Summary The benefits to be gained from a CHON will be best realized by implementing systems and processes which: Align CHI s strategic, business and clinical objectives Integrate and coordinate clinical trial, clinical research and multidisciplinary care approaches to cancer care Leverage resources and activities across the network to create internal and external efficiencies that benefit CHI and it s partners Ensure properly shared infrastructures and uniform, standardized approaches to key activities Foster timely and efficient communication and learning throughout the network 23 Contact Us J. Ike Nicoll Chief Executive Officer Cancer Clinics of Excellence 735 S. Clayton St. Denver, CO 80209 Tel: 303.722.4159 Ike.nicoll@cceclinics.com Alan Armer, Ph.D. Vice President, Research & Development Catholic Health Initiatives 1999 Broadway, Suite 2605 Denver, CO 80202 Tel: 303.383.2631 alanarmer@catholichealth.net 24 12